|
ZMIZ1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20690021812686E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29809999971364E-07 |
| Normal-vs-Stage2 |
1.58590000021164E-07 |
| Normal-vs-Stage3 |
1.00380004308676E-09 |
| Normal-vs-Stage4 |
1.4623968702665E-11 |
| Stage1-vs-Stage2 |
2.831600E-01 |
| Stage1-vs-Stage3 |
1.486010E-01 |
| Stage1-vs-Stage4 |
3.299400E-03 |
| Stage2-vs-Stage3 |
9.848600E-01 |
| Stage2-vs-Stage4 |
2.931800E-01 |
| Stage3-vs-Stage4 |
1.843970E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18010054453543E-10 |
| Normal-vs-AfricanAmerican |
4.269700E-02 |
| Normal-vs-Asian |
5.80419999999249E-05 |
| Caucasian-vs-AfricanAmerican |
5.516600E-01 |
| Caucasian-vs-Asian |
4.505600E-01 |
| AfricanAmerican-vs-Asian |
8.212400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.52219997401937E-09 |
| Normal-vs-Female |
8.42509950693682E-10 |
| Male-vs-Female |
7.769200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.54329999999536E-05 |
| Normal-vs-Age(41-60Yrs) |
3.87749998775888E-09 |
| Normal-vs-Age(61-80Yrs) |
1.77557968328301E-12 |
| Normal-vs-Age(81-100Yrs) |
7.78900000000249E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.790300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.201420E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.168430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.866500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.671200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.841200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.456500E-03 |
| Classical-VS-Follicular |
4.404700E-04 |
| Classical-VS-Other |
7.998800E-01 |
| Classical-VS-Normal |
1.45889999969562E-07 |
| Tall-VS-Follicular |
9.759400E-01 |
| Tall-VS-Other |
2.999200E-01 |
| Tall-VS-Normal |
1.79189999505169E-08 |
| Follicular-VS-Other |
4.063000E-01 |
| Follicular-VS-Normal |
3.89060006433795E-10 |
| Other-VS-Normal |
2.561700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.15429904418352E-11 |
| Normal-vs-N1 |
9.07749999612406E-08 |
| N0-vs-N1 |
9.774800E-01 |
|
|
